Form 8-K - Current report:
SEC Accession No. 0001104659-25-109815
Filing Date
2025-11-12
Accepted
2025-11-12 08:07:20
Documents
14
Period of Report
2025-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2530844d1_8k.htm   iXBRL 8-K 27166
2 EXHIBIT 99.1 tm2530844d1_ex99-1.htm EX-99.1 73312
6 GRAPHIC tm2530844d1_ex99-1img001.jpg GRAPHIC 3705
  Complete submission text file 0001104659-25-109815.txt   283967

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxs-20251112.xsd EX-101.SCH 3017
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20251112_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20251112_pre.xml EX-101.PRE 22360
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2530844d1_8k_htm.xml XML 3691
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 251469111
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)